VERIFICATION PANEL AND REFERENCE MATERIAL ARE FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.
Whether your laboratory utilises multiplex or sequential molecular testing workflows, AccuPlex™ offers quality solutions with targets for SARS-CoV-2, influenza A/B, and respiratory syncytial virus (RSV). These full-process quality solutions are designed to challenge the entire molecular test procedure from extraction to detection, ensuring clinical laboratories can have confidence in their assay results. Products are released using the US CDC Influenza SARS-CoV-2 (Flu-SC2) Multiplex Assay and Cepheid GeneXpert® Xpress SARSCoV- 2 and Flu/RSV Assays.
AccuPlex Verification Panels are optimised for assay verification at installation by documenting test performance along the assay’s range. They enable laboratories to establish lower detection limits, perform assay comparisons, and evaluate staff proficiency. AccuPlex Reference Material and Molecular Controls Kits are designed to measure the assay’s day-to-day performance, providing both a positive and negative reference solution.
Features and benefits:
- Non-infectious and replication-deficient, enables safe handling compared to viral samples.
- Fully extractable with a real viral protein coat; superior to “naked” transcribed RNA.
- Optimised for assay verification and day-to-day performance monitoring.
- Long shelf life: 2-year stability at 2 – 8°C.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
